20.65MMarket Cap
LossP/E TTM
Atossa Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Atossa Therapeutics Inc is 6.25, ranking 318 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.03, which is -15.59% below the recent high of -0.03 and -69969.71% above the recent low of -23.82.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.